The Human Lung Cancer Drug Resistance-Related Gene BC006151 Regulates Chemosensitivity in H446/CDDP Cells
スポンサーリンク
概要
- 論文の詳細を見る
This study aimed to investigate the mechanism by which the human lung cancer drug resistance-related gene BC006151 regulates chemosensitivity by down-regulating BC006151 expression via antisense gene transfer in H446/CDDP cells. A retroviral vector containing the antisense BC006151 sequence was constructed and transfected into H446/CDDP cells. Transfection of the empty vector served as a negative control. The two groups of transfected cells were treated with various chemotherapeutic agents, after which morphological changes in cell ultrastructure were compared by transmission electron microscopy, cell proliferation and chemosensitivity to particular chemotherapeutic agents were compared by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide method, the effects of chemotherapy on cell cycle and apoptosis were compared by flow cytometry, and Bcl-2 was evaluated by immunohistochemistry and Western blot analysis. Results showed that apoptotic body-like structures were identified by transmission electron microscopy in the antisense gene-transfected cells. MTT founded that these cells exhibited a significantly lower level of proliferation than the control cells (p<0.01), together with a markedly increased sensitivity to various chemotherapeutic agents (p<0.01). Flow cytometry analysis revealed that a G1 phase arrest accounted for the reduction in proliferation in the antisense gene-transfected cells; increased apoptosis was also detected (p<0.01). Both immunohistochemistry and western blot analysis confirmed that Bcl-2 expression was significantly down-regulated in the antisense gene-transfected cells compared to controls. In a word, down-regulation of BC006151 can significantly inhibit proliferation and increase apoptosis of H446/CDDP cells after chemotherapy, and this gene may play an important role in the development of multidrug resistance in lung cancer.
著者
-
Li Shujun
State Key Laboratory of Cancer Biology and Department of Gastrointestinal Surgery, Xijing Hospital,
-
Shi Hai
State Key Laboratory of Cancer Biology and Department of Gastrointestinal Surgery, Xijing Hospital,
-
Ji Fuyun
Department of Respiratory Medicine, Xinqiao Hospital, The Third Military Medical University, Peoples
-
Wang Biaoluo
State Key Laboratory of Cancer Biology and Department of Gastrointestinal Surgery, Xijing Hospital,
-
Feng Quanxin
State Key Laboratory of Cancer Biology and Department of Gastrointestinal Surgery, Xijing Hospital,
-
Feng Xiangying
State Key Laboratory of Cancer Biology and Department of Gastrointestinal Surgery, Xijing Hospital,
-
Jia Zhiyu
Department of Oral and Maxillafacial Surgery, The Second Hospital of Hebei Medical University
-
Zhao Qingchuan
State Key Laboratory of Cancer Biology and Department of Gastrointestinal Surgery, Xijing Hospital,
-
Qian Guisheng
Department of Respiratory Medicine, Xinqiao Hospital, The Third Military Medical University, Peoples
-
Shi Hai
State Key Laboratory Of Cancer Biology Department Of Gastrointestinal Surgery Xijing Hospital The Fo
-
Shi Hai
State Key Laboratory Of Cancer Biology And Department Of Gastrointestinal Surgery Xijing Hospital Th
-
Li Shujun
State Key Laboratory Of Cancer Biology Department Of Gastrointestinal Surgery Xijing Hospital The Fo
-
Qian Guisheng
Department of Respiratory Medicine, Xinqiao Hospital, The Third Military Medical University, People's Republic of China
-
Ji Fuyun
Department of Respiratory Medicine, Xinqiao Hospital, The Third Military Medical University, People's Republic of China
-
Li Shujun
State Key Laboratory of Cancer Biology and Department of Gastrointestinal Surgery, Xijing Hospital, The Fourth Military Medical University, People's Republic of China
-
Shi Hai
State Key Laboratory of Cancer Biology and Department of Gastrointestinal Surgery, Xijing Hospital, The Fourth Military Medical University, People's Republic of China
-
Feng Xiangying
State Key Laboratory of Cancer Biology and Department of Gastrointestinal Surgery, Xijing Hospital, The Fourth Military Medical University, People's Republic of China
-
Zhao Qingchuan
State Key Laboratory of Cancer Biology and Department of Gastrointestinal Surgery, Xijing Hospital, The Fourth Military Medical University, People's Republic of China
-
Feng Quanxin
State Key Laboratory of Cancer Biology and Department of Gastrointestinal Surgery, Xijing Hospital, The Fourth Military Medical University, People's Republic of China
関連論文
- The Human Lung Cancer Drug Resistance-Related Gene BC006151 Regulates Chemosensitivity in H446/CDDP Cells
- Bmi-1 is related to proliferation, survival and poor prognosis in pancreatic cancer
- Expression of NDRG2 in esophageal squamous cell carcinoma
- Downregulation of MSP58 inhibits growth of human colorectal cancer cells via regulation of the cyclin D1-cyclin-dependent kinase 4-p21 pathway
- Suppression of N-Myc Downstream-Regulated Gene 2 Is Associated with Induction of Myc in Colorectal Cancer and Correlates Closely with Differentiation